logo

Esomeprazole Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Esomeprazole market is segmented By Dosage Type (Tablets, Capsules, Others), Application, and Geography.

Home Industry Reports Healthcare Esomeprazole Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 202 ...

Market Snapshot

Market Snapshot
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Esomeprazole market is expected to register a 5% of CAGR over the forecast period. The major contributing factor in market growth is increasing the prevalence of GERD. Gastroesophageal reflux disease is a chronic and highly prevalent disorder. It is majorly found in the middle-aged and older population. Ageing has been often associated with the GERD. 

According to the report “World Ageing Population, 2019”, approximately 702.9 million geriatric population was reported globally. Furthermore, the combination of non-steroidal anti-inflammatory drugs and proton pump inhibitors reduces the risk of lower gastrointestinal bleeding. Hence, it is expected to drive the esomeprazole market growth.

Scope of the Report

Esomeprazole is a type of proton pump inhibitor that is used for treating gastrointestinal disease such as peptic ulcers, Zollinger Ellison Syndrome, etc. It lowers the acidic level by decreasing it’s production in the stomach. Esomeprazole Market is segmented By Dosage Type, By Application, and Geography.

By Dosage Type
Tablets
Capsules
Others
By Application
Gastroesophageal Reflux Disease (GERD)
Stomach Ulcers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Capsules Segment is Expected to Exhibhit a Significant Market Growth in the Esomeprazole Market

  • Capsules segment is expected to grow at a significant rate in the Esomeprazole market. In 2019, Zydus Cadila received a delayed-release US FDA (Food & Drug Administration) approval to manufacture and market esomeprazole magnesium delayed – release capsules. It is used to treat the symptoms of gastroesophageal reflux disease, to reduce the risk of stomach ulcers in some people taking pain medicines, to treat patients with a stomach infection (Helicobacter pylori).
  • Furthermore, as per the data of “Gastroenterology,2017” Africa had the highest rate of H.Pylori infection with about affecting 70.1% of the population. South America reported with approximately 69.4% of prevalence while Western Asia accounted for around 66.6% of the infection. Thus, the capsule segment is expected to influence positively on market growth.
Esome.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Esomeprazole market owing to the rising geriatric population and the increasing presence of product approvals. The older population is at a higher risk of developing gastrointestinal diseases such as gastroesophageal reflux disease. According to the U.S. Census Bureau, in 2018, around 52 million older population was living in the United States. 

In 2020, Cipla received a US FDA (Food & Drug Administration) to manufacture the generic version of Nexium. It is used for treating GERD, Zollinger-Ellison Syndrome, reducing the risk of NSAIDS associated gastric ulcers, and H.pylori eradication. Thus, the aforementioned factors are expected to boost the market.

Esomeprazole Market - Growth Rate by Region

Competitive Landscape

Key players that are expected to be dominant in Esomeprazole market are Daiichi Sankyo, Astrazeneca PLC, Zydus Pharmaceuticals Inc., Sun Pharmaceutical Industries Inc., Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Dr. Reddy's Laboratories Inc., Torrent Pharma Inc., Amneal Pharmaceuticals LLC and Glenmark Pharmaceuticals

Esomeprazole Market Concentration.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Gastrophageal Reflux Disease (GERD)

      2. 4.2.2 Rising Acceptance of Novel Drug Delivery Systems

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Framework

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Dosage Type

      1. 5.1.1 Tablets

      2. 5.1.2 Capsules

      3. 5.1.3 Others

    2. 5.2 By Application

      1. 5.2.1 Gastroesophageal Reflux Disease (GERD)

      2. 5.2.2 Stomach Ulcers

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Daiichi Sankyo

      2. 6.1.2 Astrazeneca PLC

      3. 6.1.3 Zydus Pharmaceuticals Inc.

      4. 6.1.4 Sun Pharmaceutical Industries Inc.

      5. 6.1.5 Teva Pharmaceuticals USA, Inc.

      6. 6.1.6 Mylan Pharmaceuticals Inc.

      7. 6.1.7 Dr. Reddy's Laboratories Inc.

      8. 6.1.8 Torrent Pharma Inc.

      9. 6.1.9 Amneal Pharmaceuticals LLC

      10. 6.1.10 Glenmark Pharmaceuticals

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Esomeprazole Market market is studied from 2018 - 2026.

The Esomeprazole Market is growing at a CAGR of 5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Daiichi Sankyo, Zydus Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Teva Pharmaceuticals, Amneal Pharmaceuticals are the major companies operating in Esomeprazole Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!